TrialInternational journal of hematology2017
Safety and efficacy of mogamulizumab in patients with adult T-cell leukemia-lymphoma in Japan: interim results of postmarketing all-case surveillance.
Kenji Ishitsuka et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled itcites it